Celebrex Related Published Studies
Well-designed clinical trials related to Celebrex (Celecoxib)
Topical capsaicin (low concentration) for chronic neuropathic pain in adults. [2012]
Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. [2011.12.24]
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. [2011.11]
A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. [2011.10.30]
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. [2011.10]
The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial. [2011.09]
Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial. [2011.07.19]
Lung cancer chemoprevention with celecoxib in former smokers. [2011.07]
Efficacy of low-dose celecoxib in patients with acute pain. [2011.07]
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. [2011.06]
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial. [2011.05]
Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. [2011.03]
The cyclooxygenase-2 inhibitor celecoxib and alveolar osteitis. [2011.02]
The effects of oral ibuprofen and celecoxib in preventing pain, improving recovery outcomes and patient satisfaction after ambulatory surgery. [2011.02]
Effects of celecoxib on major prostaglandins in asthma. [2011.01]
A randomized controlled trial of celecoxib to prevent recurrence of
nonmuscle-invasive bladder cancer. [2011]
A preliminary randomized double-blind clinical trial on the efficacy of celecoxib
as an adjunct in the treatment of obsessive-compulsive disorder. [2011]
The use of etoricoxib and celecoxib for pain prevention after periodontal
surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical
trial. [2011]
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. [2010.12.15]
An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. [2010.12]
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. [2010.11]
Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial. [2010.10.25]
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer. [2010.10]
The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty. [2010.08]
Effect of celecoxib combined with thoracic epidural analgesia on pain after thoracotomy. [2010.08]
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. [2010.08]
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. [2010.08]
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. [2010.07.17]
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients. [2010.07]
Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial. [2010.06.01]
The safety and efficacy of celecoxib in children with familial adenomatous polyposis. [2010.06]
Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis. [2010.05]
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. [2010.05]
Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema. [2010.03]
An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis. [2010.02.02]
Biological activity of celecoxib in the bronchial epithelium of current and former smokers. [2010.02]
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized,
double-blind, placebo-controlled trial. [2010]
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and
rheumatoid arthritis (CONDOR): a randomised trial. [2010]
Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac:
pooled results from three 12-week trials in Chinese patients with osteoarthritis
or rheumatoid arthritis. [2010]
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their
combination, celecoxib or placebo taken to treat osteoarthritis of the knee:
2-year results from GAIT. [2010]
The safety and efficacy of celecoxib in children with familial adenomatous
polyposis. [2010]
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. [2009.12]
Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo. [2009.11.15]
Efficacy and safety of celecoxib in the treatment of acute pain due to ankle sprain in a Latin American and Middle Eastern population. [2009.11]
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer. [2009.11]
Celecoxib in the management of acute renal colic: a randomized controlled clinical trial. [2009.11]
[Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene] [2009.11]
Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers. [2009.10.20]
Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA). [2009.10]
Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling. [2009.09]
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. [2009.08]
Celecoxib in the Management of Acute Renal Colic: A Randomized Controlled Clinical Trial. [2009.07.08]
Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study. [2009.06.15]
Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. [2009.06.14]
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. [2009.06.09]
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. [2009.06]
Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. [2009.06]
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer. [2009.05]
A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing. [2009.04.01]
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. [2009.04]
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. [2009.04]
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. [2009.04]
A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. [2009.03]
Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use. [2009.03]
A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. [2009.03]
Celecoxib does not appear to affect prosthesis fixation in total knee replacement: A randomized study using radiostereometry in 50 patients. [2009.02]
[Effects of perioperative administration of celecoxib on pain management and recovery of function after total knee replacement] [2009.01.15]
A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. [2009.01]
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. [2008.12]
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. [2008.12]
Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. [2008.10]
[Postoperative analgesia after laparoscopic cholecystectomy: comparison of the preoperative administration of celecoxib with paracetamol?] [2008.10]
Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation. [2008.08]
Celecoxib-related gastroduodenal ulcer and cardiovascular events in a randomized trial for gastric cancer prevention. [2008.07.28]
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer. [2008.07]
Perioperative celecoxib administration for pain management after total knee arthroplasty - a randomized, controlled study. [2008.06.03]
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. [2008.06]
Aberrant crypt foci in the adenoma prevention with celecoxib trial. [2008.06]
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib. [2008.05.12]
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo. [2008.05]
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. [2008.05]
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. [2008.04.22]
Pilot randomized phase II study of celecoxib in oral premalignant lesions. [2008.04.01]
A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes. [2008.04]
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib. [2008.03.10]
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis. [2008.03.07]
Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. [2008.03]
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. [2008.03]
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. [2008.03]
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial. [2008.03]
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. [2008.02.20]
Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial. [2008.02]
The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis. [2008.01]
Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial. [2008.01]
Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. [2008.01]
Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. [2008.01]
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. [2007.12]
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis. [2007.12]
Lumiracoxib 400 mg Compared With Celecoxib 400 mg and Placebo for Treating Pain Following Dental Surgery: A Randomized, Controlled Trial. [2007.10.13]
Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial. [2007.10]
Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. [2007.10]
|
